Norway will not use AstraZeneca Covid-19 vaccine
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Norway will not use AstraZeneca Covid-19 vaccine

Coronavirus chronicle

Reuters
12 May, 2021, 04:15 pm
Last modified: 12 May, 2021, 04:19 pm

Related News

  • Four people stabbed in south-east Norway attack
  • Denmark, Iceland and Norway 'strongly welcome' Finnish and Swedish decision to apply for NATO membership
  • We are 100% behind Finnish, Swedish NATO membership, Norway tells Turkey
  • Norway shuts borders, ports to Russian goods, exempts fishing vessels
  • Britain to send Stormer armoured vehicles to Ukraine

Norway will not use AstraZeneca Covid-19 vaccine

A study in Denmark and Norway found slightly increased rates of vein blood clots among people who have had a first dose of AstraZeneca's vaccine, including clots in the brain, compared with expected rates in the general population

Reuters
12 May, 2021, 04:15 pm
Last modified: 12 May, 2021, 04:19 pm
A medical worker prepares a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. File Photo:Reuters
A medical worker prepares a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. File Photo:Reuters

Norway will not resume its use of the COVID-19 vaccine made by AstraZeneca due to a risk of rare but harmful side-effects, newspaper VG reported on Wednesday.

Prime Minister Erna Solberg is expected to announce at 1600 GMT whether Norway will resume the use of the AstraZeneca shot, as well as the government's decision on Johnson & Johnson's inoculation.

The prime minister's office and the health ministry were not immediately available for comment.

Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.

A study in Denmark and Norway found slightly increased rates of vein blood clots among people who have had a first dose of AstraZeneca's vaccine, including clots in the brain, compared with expected rates in the general population.

On May 10, a public panel of medical, legal and other experts said the two vaccines should not be offered as part of the national inoculation scheme, although volunteers should be allowed to take them. 

Norway / AstraZeneca Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infographic: TBS
    Tough conditions get in way of Indian wheat import
  • Zahid Hussain/TBS Sketch
    Our problematic macroeconomic duo
  • US growth seen outpacing China’s for first time since 1976
    US growth seen outpacing China’s for first time since 1976

MOST VIEWED

  • A worker disinfects a vehicle carrying medical oxygen, in Pyongyang. Photo: Collected
    North Korea using traditional medicine to fight Covid
  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial

Related News

  • Four people stabbed in south-east Norway attack
  • Denmark, Iceland and Norway 'strongly welcome' Finnish and Swedish decision to apply for NATO membership
  • We are 100% behind Finnish, Swedish NATO membership, Norway tells Turkey
  • Norway shuts borders, ports to Russian goods, exempts fishing vessels
  • Britain to send Stormer armoured vehicles to Ukraine

Features

Mohammad (Mejbah) Mejbahuddin, Former Senior Secretary, Economic Relations Division (ERD), Ministry of Finance, Government of Bangladesh. TBS Sketch

‘No project is being delayed too long at the moment’

7h | Panorama
Dr Shamsul Hoque, Professor, Civil Engineering, BUET. TBS Sketch

‘Planning commission only in the name, there are no planners’ 

7h | Panorama
Masrur Reaz. TBS Sketch

‘To ensure accountability, contract financing should be based on ‘performance based payments’

7h | Panorama
Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

11h | Panorama

More Videos from TBS

Ways to retain body fragrance

Ways to retain body fragrance

9h | Videos
Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

12h | Videos
How to prepare for a job

How to prepare for a job

13h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

1d | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

6
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab